These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 21228582

  • 1. A quantitative approach to drug dosing in chronic kidney disease.
    Olyaei AJ, Steffl JL.
    Blood Purif; 2011; 31(1-3):138-45. PubMed ID: 21228582
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis.
    Velenosi TJ, Urquhart BL.
    Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1131-43. PubMed ID: 24961255
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Drug dosing adjustments in patients with chronic kidney disease.
    Munar MY, Singh H.
    Am Fam Physician; 2007 May 15; 75(10):1487-96. PubMed ID: 17555141
    [Abstract] [Full Text] [Related]

  • 7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 May 15; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Disease management in chronic kidney disease.
    Rastogi A, Linden A, Nissenson AR.
    Adv Chronic Kidney Dis; 2008 Jan 15; 15(1):19-28. PubMed ID: 18155106
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T.
    Ther Apher Dial; 2010 Jun 15; 14(3):240-75. PubMed ID: 20609178
    [Abstract] [Full Text] [Related]

  • 13. Drug dosing in patients with impaired renal function.
    Brater DC.
    Clin Pharmacol Ther; 2009 Nov 15; 86(5):483-9. PubMed ID: 19626002
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics in patients with renal failure.
    Maher JF.
    Clin Nephrol; 1984 Jan 15; 21(1):39-46. PubMed ID: 6368069
    [Abstract] [Full Text] [Related]

  • 17. Drug development perspective on pharmacokinetic studies of new drugs in patients with renal impairment.
    Lalonde RL, Wagner JA.
    Clin Pharmacol Ther; 2009 Nov 15; 86(5):557-61. PubMed ID: 19776736
    [Abstract] [Full Text] [Related]

  • 18. Understanding renal replacement therapy and dosing of drugs in pediatric patients with kidney disease.
    Zuppa AF.
    J Clin Pharmacol; 2012 Jan 15; 52(1 Suppl):134S-40S. PubMed ID: 22232749
    [Abstract] [Full Text] [Related]

  • 19. Treatment of hypertension in chronic kidney disease.
    Toto RD.
    Semin Nephrol; 2005 Nov 15; 25(6):435-9. PubMed ID: 16298269
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.